Evidence map›Paper›PMID 30608578›Full record

ArticleHuman molecular genetics2019

EAP1 regulation of GnRH promoter activity is important for human pubertal timing.

Alessandra Mancini, Sasha R Howard, Claudia P Cabrera, Michael R Barnes, Alessia David, Karoliina Wehkalampi, Sabine Heger, Alejandro Lomniczi, Leonardo Guasti, Sergio R Ojeda and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Genetics of Idiopathic Hypogonadotropic HypogonadismJournal of clinical research in pediatric endocrinology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Disorders of puberty and neurodevelopment: A shared etiology?Annals of the New York Academy of Sciences · 2024
    Review
  6. Review
  7. Genetics of pubertal delay.Clinical endocrinology · 2022
    Review
  8. Review
  9. Genetics of pubertal timing.Best practice & research. Clinical endocrinology & metabolism · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. DLG2 variants in patients with pubertal disorders.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  16. Article
  17. Review
  18. Review
  19. The Genetic Basis of Delayed Puberty.Frontiers in endocrinology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Alessandra ManciniCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Sasha R HowardCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Claudia P CabreraCentre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Michael R BarnesCentre for Translational Bioinformatics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Alessia DavidCentre for Integrative Systems Biology and Bioinformatics, Department of Life Sciences, Imperial College London, London, UK.
Karoliina WehkalampiChildren's Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Sabine HegerDepartment of Pediatric Endocrinology, Children's Hospital Auf der Bult, Hannover, Germany.
Alejandro LomnicziOregon National Primate Research Center/Oregon Health and Science University, Portland, OR, USA.
Leonardo GuastiCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Sergio R OjedaOregon National Primate Research Center/Oregon Health and Science University, Portland, OR, USA.
Leo DunkelCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Queen Mary University of London · GBWilliam Harvey Research Institute · GBOregon Health & Science University · USImperial College London · GBKinderkrankenhaus auf der Bult · DEUniversity of Helsinki · FI

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Metabolic Control of Puberty: Epigenetic LinksR01HD084542 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI LOMNICZI, ALEJANDRO · 2015 to 2019
$2.6M
Biotechnology and Biological Sciences Research Council BB/L002671/1NICHD NIH HHS R01 HD084542NIH HHS P51 OD011092Wellcome Trust 102745Wellcome Trust 105519/Z/14/Z
6 · The paper itself

Abstract

The initiation of puberty is orchestrated by an augmentation of gonadotropin-releasing hormone (GnRH) secretion from a few thousand hypothalamic neurons. Recent findings have indicated that the neuroendocrine control of puberty may be regulated by a hierarchically organized network of transcriptional factors acting upstream of GnRH. These include enhanced at puberty 1 (EAP1), which contributes to the initiation of female puberty through transactivation of the GnRH promoter. However, no EAP1 mutations have been found in humans with disorders of pubertal timing. We performed whole-exome sequencing in 67 probands and 93 relatives from a large cohort of familial self-limited delayed puberty (DP). Variants were analyzed for rare, potentially pathogenic variants enriched in case versus controls and relevant to the biological control of puberty. We identified one in-frame deletion (Ala221del) and one rare missense variant (Asn770His) in EAP1 in two unrelated families; these variants were highly conserved and potentially pathogenic. Expression studies revealed Eap1 mRNA abundance in peri-pubertal mouse hypothalamus. EAP1 binding to the GnRH1 promoter increased in monkey hypothalamus at the onset of puberty as determined by chromatin immunoprecipitation. Using a luciferase reporter assay, EAP1 mutants showed a reduced ability to trans-activate the GnRH promoter compared to wild-type EAP1, due to reduced protein levels caused by the Ala221del mutation and subcellular mislocation caused by the Asn770His mutation, as revealed by western blot and immunofluorescence, respectively. In conclusion, we have identified the first EAP1 mutations leading to reduced GnRH transcriptional activity resulting in a phenotype of self-limited DP.

Indexed as

AdolescentAdultAnimalsChildExome SequencingFemaleGene Expression RegulationGonadotropin-Releasing HormoneHumansHypothalamusMaleMiceMiddle AgedNeuronsPromoter Regions, GeneticPubertyGonadotropin-Releasing Hormonepituitary tumor-transforming protein 1, humanRNA, MessengerSecurinTrans-ActivatorsTranscription Factors

Identifiers

PMID30608578
PMCPMC6452208
OpenAlexW2907777164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.